Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
TriSalus Life Sciences, Inc. (TLSI) had Free Cash Flow per Share of $-0.50 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$13.21M |
|
$-8.33M |
|
$1.76M |
|
$11.44M |
|
$16.48M |
|
$-3.27M |
|
$-6.48M |
|
$-9.75M |
|
$-9.75M |
|
$-9.75M |
|
$-9.75M |
|
$-9.75M |
|
$-9.75M |
|
$-3.27M |
|
$-2.86M |
|
37.90M |
|
37.90M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$32.24M |
|
$1.81M |
|
$3.09M |
|
$35.33M |
|
$11.50M |
|
$33.05M |
|
$57.69M |
|
$69.19M |
|
$-33.86M |
|
$-33.86M |
|
$-33.86M |
|
50.00M |
|
| Cash Flow Statement Financials | |
$-18.01M |
|
$-0.84M |
|
$30.76M |
|
$8.88M |
|
$20.79M |
|
$11.91M |
|
$9.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.80 |
|
-- |
|
-- |
|
-40.55 |
|
-0.98 |
|
86.66% |
|
-24.77% |
|
-24.77% |
|
-- |
|
-73.86% |
|
-63.06% |
|
$-18.85M |
|
-- |
|
-- |
|
-- |
|
0.37 |
|
0.57 |
|
2.01 |
|
44.70 |
|
28.80% |
|
28.80% |
|
-27.60% |
|
1196.69% |
|
$-0.68 |
|
|
Free Cash Flow per Share |
$-0.50 |
$-0.48 |
|